Imperial College London
Portrait Picture

DrRuthPeters

Faculty of Medicine, School of Public Health

Honorary Research Fellow
 
 
 
//

Contact

 

+44 (0)20 7594 8974r.peters

 
 
//

Location

 

Stadium HouseWhite City Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Peters:2022:10.1002/alz.12393,
author = {Peters, R and Dodge, HH and James, S and Jicha, GA and Meyer, P-F and Richards, M and Smith, AD and Yassine, HN and Abner, E and Hainsworth, AH and Kehoe, PG and Beckett, N and Anderson, CS and Anstey, KJ},
doi = {10.1002/alz.12393},
journal = {ALZHEIMERS & DEMENTIA},
pages = {507--512},
title = {The epidemiology is promising, but the trial evidence is weak. Why pharmacological dementia risk reduction trials haven't lived up to expectations, and where do we go from here?},
url = {http://dx.doi.org/10.1002/alz.12393},
volume = {18},
year = {2022}
}
Download

RIS format (EndNote, RefMan)

TY  - JOUR
AU  - Peters,R
AU  - Dodge,HH
AU  - James,S
AU  - Jicha,GA
AU  - Meyer,P-F
AU  - Richards,M
AU  - Smith,AD
AU  - Yassine,HN
AU  - Abner,E
AU  - Hainsworth,AH
AU  - Kehoe,PG
AU  - Beckett,N
AU  - Anderson,CS
AU  - Anstey,KJ
DO  - 10.1002/alz.12393
EP  - 512
PY  - 2022///
SN  - 1552-5260
SP  - 507
TI  - The epidemiology is promising, but the trial evidence is weak. Why pharmacological dementia risk reduction trials haven't lived up to expectations, and where do we go from here?
T2  - ALZHEIMERS & DEMENTIA
UR  - http://dx.doi.org/10.1002/alz.12393
UR  - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000713640500001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=a2bf6146997ec60c407a63945d4e92bb
VL  - 18
ER  -
Download